Rosuvastatin-Induced Rhabdomyolysis - Possible Role of Ticagrelor and Patients’ Pharmacogenetic Profile-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Rosuvastatin-Induced Rhabdomyolysis - Possible Role of Ticagrelor and Patients’ Pharmacogenetic Profile

Published:2018-06-29 Issue:4 Volume:123 Page:509-518
ISSN:1742-7835
Container-title:Basic & Clinical Pharmacology & Toxicology
language:en
Short-container-title:Basic Clin Pharmacol Toxicol

Author:

Vrkić Kirhmajer Majda¹,Macolić Šarinić Viola²,Šimičević Livija³,Ladić Iva⁴,Putarek Krešimir⁵,Banfić Ljiljana¹,Božina Nada⁶

Affiliation:

1. Department of Cardiovascular Diseases; University of Zagreb School of Medicine; University Hospital Centre Zagreb; Zagreb Croatia

2. Safety and Vigilance; WHO; Geneva Switzerland

3. Department of Laboratory Diagnostics; University Hospital Centre Zagreb; Zagreb Croatia

4. Department of Internal Medicine; Bjelovar General Hospital; Bjelovar Croatia

5. Department of Cardiovascular Diseases; University Hospital Centre Zagreb; Zagreb Croatia

6. Department of Pharmacology; University of Zagreb School of Medicine; University Hospital Centre Zagreb; Zagreb Croatia

Publisher

Wiley

Subject

Pharmacology,Toxicology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bcpt.13035/fullpdf

Reference36 articles.

1. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC);Ibanez;Eur Heart J,2018

2. Statin-associated muscle symptoms: impact on statin therapy-European atherosclerosis society consensus panel statement on assessment, Aetiology and management;Stroes;Eur Heart J,2015

3. Association between statin-induced creatine kinase elevation and genetic polymorphisms in SLCO1B1, ABCB1 and ABCG2;Ferrari;Eur J Clin Pharmacol,2014

4. Pharmacokinetic interaction studies of co-administration of ticagrelor and atorvastatin or simvastatin in healthy volunteers;Teng;Eur J Clin Pharmacol,2013

5. Genetic factors affecting statin concentrations and subsequent myopathy: a HuGENet systematic review;Canestaro;Genet Med,2014

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A disproportionality analysis of FDA adverse event reporting system (FAERS) events for ticagrelor;Frontiers in Pharmacology;2024-04-09

2. Statins Ticagrelor and Rhabdomyolysis: A Coincidence or a Drug Interaction?;Journal of Lipid and Atherosclerosis;2024

3. Ticagrelor Increases Exposure to the Breast Cancer Resistance Protein Substrate Rosuvastatin;Clinical Pharmacology & Therapeutics;2023-10-20

4. Differential effects of OATP2B1 on statin accumulation and toxicity in a beta cell model;Toxicology Mechanisms and Methods;2023-09-28

5. Rhabdomyolysis with Co-Administration of Statins and Antiplatelet Therapies—Analysis of the WHO Pharmacovigilance Database;Cardiovascular Drugs and Therapy;2023-04-28

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3